53.9 F
New York
Wednesday, October 28, 2020

Mylan N.V. (NASDAQ:MYL) Recent Earnings Shows Major Promise

Must read

Extreme Networks Inc. (NASDAQ:EXTR) Stock is Plummeting, Here is Why

Extreme Networks Inc. (EXTR) shares are trading at lower $4.62 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

Renewed Optimism is Surrounding Lululemon Athletica Inc. (NASDAQ:LULU)

Lululemon Athletica Inc. (LULU) shares are trading at lower $331.60 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

Is Now the Time to Invest in Atara Biotherapeutics Inc. (NASDAQ:ATRA)?

Atara Biotherapeutics Inc. (ATRA) shares are trading at lower $14.34 and the avg recommendation for the stock is Moderate Buy. To add more color...

Fortinet Inc. (NASDAQ:FTNT) is Gaining Momentum on Earnings Catalyst

Fortinet Inc. (FTNT) shares are trading at lower $123.18 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Mylan N.V. (MYL) shares are trading at higher $15.72 and the avg recommendation for the stock is Moderate Buy, while the current analyst price target stands at $22.00.

To add more color to this target, the company’s high over the last year is $23.11 and the low is $12.75. Over the last 52 weeks, MYL is down -14.70% while the S&P 500 is up 18.03%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, MYL reported a profit of $1.03 billion. Mylan N.V. also saw revenues increase to $2.73 billion. In addition, MYL has free cash flow of $582.7 million as of 06-2020. The company’s EBITDA came in at $549.9 million which compares well with its peers.

MYL booked profit margins of 2.40%, its Return on Equity (ROE) is 2.30%, and its Return on Assets is 0.90%. All told, it is clear that, MYL needs to be on your watchlist.

Find out when MYL reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. MYL has a short ratio of 8.60 and outstanding shares of 516.90M.

Company Outlook

MYL has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 4.54 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at 0.52. Mylan N.V. MYL also noted assets of $30.16 billion at the end of the last quarter. Investors should also keep an eye on sector updates as MYL has historically followed its peers on positive news.

All told, Mylan N.V. MYL has strung together solid data and demonstrated underlying fundamentals. At its current valuation, MYL represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Mylan N.V. MYL is now commanding a market cap of 8.08B and a float of 510.93M. MYL is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of MYL stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in MYL, either long or short, and we have not been compensated for this article.

Latest article

The Forecast Just Changed on Kala Pharmaceuticals Inc. (NASDAQ:KALA)

Kala Pharmaceuticals Inc. (KALA) shares are trading at lower $6.28 and the avg recommendation for the stock is Strong Buy. To add more color...

1847 Goedeker Inc. (AMEX:GOED) on the Path to Profitability

1847 Goedeker Inc. (GOED) shares are trading at higher $8.27. To add more color to this target, the company’s high over the last year...

Is Now the Time to Invest in Staffing 360 Solutions Inc. (NASDAQ:STAF)?

Staffing 360 Solutions Inc. (STAF) shares are trading at lower $1.23 and the avg recommendation for the stock is Moderate Buy. To add more...

Catabasis Pharmaceuticals Inc. (NASDAQ:CATB) Stock is Plummeting, Here is Why

Catabasis Pharmaceuticals Inc. (CATB) shares are trading at lower $1.56 and the avg recommendation for the stock is Strong Buy. To add more color...

Scholar Rock Holding Corporation (NASDAQ:SRRK) is Holding Steady

Scholar Rock Holding Corporation (SRRK) shares are trading at higher $30.02 and the avg recommendation for the stock is Strong Buy. To add more...